Analysis of prognostic factors affecting immune checkpoint inhibitor therapy in tumor patients exposed to antibiotics
ObjectiveMeta-analysis was performed to evaluate the prognostic factors in tumor patients treated with immune checkpoint inhibitors (ICIs) under antibiotic exposure.MethodLiterature on the effect of antibiotics on the prognosis of tumor patients receiving ICIs was retrieved from Pubmed, Cochrane Lib...
Main Authors: | Qian Chen, Zhen Zhang, Xiaoli Li, Shaomei Feng, Shui Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1204248/full |
Similar Items
-
Efficacy and safety of molecularly targeted agents and immune checkpoint inhibitors for unresectable or recurrent/metastatic oral cancer in Japan
by: Mitsunobu Otsuru, et al.
Published: (2024-07-01) -
The association between antibiotic use and outcomes of HCC patients treated with immune checkpoint inhibitors
by: Lilong Zhang, et al.
Published: (2022-08-01) -
Clinical impact of heterogeneously distributed tumor-infiltrating lymphocytes on the prognosis of colorectal cancer
by: Lu Liu, et al.
Published: (2024-01-01) -
Early Alpha-Fetoprotein Response Predicts Sustained Tumor Response Following Immune Checkpoint Inhibitors Combined with Targeted Therapy in Liver Cancer
by: Jiahe Tian, et al.
Published: (2024-12-01) -
Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study
by: Lianxi Song, et al.
Published: (2023-05-01)